Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients
Author(s) -
Jingtao Gao,
Yi Pei,
Xiaofeng Yan,
Guomin Shi,
Tongxin Li,
Mengqiu Gao,
Yuhong Liu,
Yufeng Wang,
Wei Shu,
Liang Li,
Yu Pang
Publication year - 2020
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2020.08.080
Subject(s) - bedaquiline , nontuberculous mycobacteria , medicine , tuberculosis , culture conversion , sputum , multiple drug resistance , sputum culture , mycobacterium abscessus , drug resistance , microbiology and biotechnology , mycobacterium tuberculosis , pathology , mycobacterium , biology
The World Health Organization recommends the use of bedaquiline (BDQ) to formulate efficacious combination regimens against multidrug-resistant tuberculosis (MDR-TB). This study reports, for the first time, a case series of MDR-TB patients treated with BDQ who experienced sputum culture reconversion due to emergence of nontuberculous mycobacteria (NTM) infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom